Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 25.02
-0.94 (-3.62%)
May 12, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.05 billion as of May 12, 2026. Its market cap has increased by 6.39% in one year.
Market Cap
5.05B
Enterprise Value
4.79B
Revenue
1.74B
Ranking
n/a
PE Ratio
17.66
Stock Price
25.02
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.05B, a decrease of -26.13%. That is a compound annual growth rate of -5.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 5.24B | 25.36% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 5.87B |
| PharmaResources (Shanghai) | 5.86B |
| Lifecome Biochemistry | 5.86B |
| Shenzhen Weiguang Biological Products | 5.85B |
| Beijing Konruns Pharmaceutical | 5.61B |
| Jiangsu Bioperfectus Technologies | 5.37B |
| ChemPartner PharmaTech | 5.00B |
| Kexing Biopharm | 4.96B |